ArticleAntibiotics (Basel, Switzerland)2026

Clinical Outcomes and Healthcare Resource Utilization of Ceftolozane/Tazobactam in Vulnerable Patient Populations.

Emre Yücel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.